Literature DB >> 3040242

The development of hepatocellular cancer in humans.

M C Kew.   

Abstract

The biological characteristics of hepatocellular cancer vary appreciably in different parts of the world, but especially between regions with very high and low incidences of the tumour. Hepatocellular cancer is multifactorial in origin, and the pattern of its aetiological associations differs between populations at high and low risk. In Africans and Chinese, who have the highest incidences of hepatocellular cancer, the hepatitis B virus is the most important causal association. The viral carrier state is acquired during early childhood, and carries a relative risk for the development of the tumour of over 200. Integration of hepatitis B virus DNA probably acts as a genotoxic initiator in the multistep process of hepatocarcinogenesis, although the precise mechanisms involved have not been determined. Aflatoxin ingestion may also have an aetiological role in high incidence regions, probably as a genotoxic or epigenetic promoter to hepatitis B virus-initiated carcinogenesis. In low risk populations cirrhosis is the most important causal association of hepatocellular cancer. The cirrhosis is often the result of alcohol abuse, but the tumour may complicate all aetiological forms of this disease. Whether neoplasia is an inevitable consequence of the hyperplasia of cirrhosis, or the increased hepatocyte turnover rate acts as a promoter is not known. Hepatitis B virus infection plays a lesser part, and aflatoxin no part at all.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3040242

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  9 in total

1.  Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection.

Authors:  F M Shen; M K Lee; H M Gong; X Q Cai; M C King
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

Review 2.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

Review 3.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Current management of hepatocellular cancer.

Authors:  Bernardino Rampone; Beniamino Schiavone; Giuseppe Confuorto
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

5.  Recent developments in the first detection of hepatocellular carcinoma.

Authors:  Joseph B Lopez
Journal:  Clin Biochem Rev       Date:  2005-08

Review 6.  Current management strategy of hepatocellular carcinoma.

Authors:  Bernardino Rampone; Beniamino Schiavone; Antonio Martino; Carmine Viviano; Giuseppe Confuorto
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

7.  Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.

Authors:  M Lu; G Hilken; J Kruppenbacher; T Kemper; R Schirmbeck; J Reimann; M Roggendorf
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 8.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

9.  Hepatic bipolar radiofrequency ablation creates coagulation zones close to blood vessels: a finite element study.

Authors:  D Haemmerich; A W Wright; D M Mahvi; F T Lee; J G Webster
Journal:  Med Biol Eng Comput       Date:  2003-05       Impact factor: 2.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.